JPRN-UMIN000034129已完成未知
Efficacy trial of continuous ingestion of plant derived ingredients. [trial number g2018006] - Efficacy of plant derived ingredients. [trial number g2018006]
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
o significant difference in the primary outcome
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 64years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1)Subjects diagnosed with diabetes, or taking drugs related diabetes (2)Subjects who have history or symptom of cardiovascular disease or cerebrovascular disease (3)Subjects who have symptom of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (4)Subjects who have a history of resection of gastrointestinal tract, excluding cecal resection surgery (5)Heavy drinker (over 30g alcohol per day) (6)Subjects who have donated over 200 mL of blood within the last one month prior to the current study or over 400 mL of blood within the last three months prior to the study (7)Subjects who have severe anemia (Hb <=7g/dL) (8)Subjects who have food allergies for test foods (9)Subjects who plan to participate in other clinical study during the current study (10)Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reasons
研究者
相似试验
已完成
不适用
Efficacy trial of ingestion of plant derived ingredient. [g2020004(KO22)]Healthy adultsJPRN-UMIN000041485Kao Corporation16
已完成
不适用
Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]JPRN-UMIN000047544Kao Corporation18
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [g2018003]Adults with diabetic range of fasting glucose (fasting plasma glucose, 126-160 mg/dl)JPRN-UMIN000032374Kao Corporation9
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [g2019004]Healthy adultsJPRN-UMIN000037738Kao Corporation18
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [g2018002]Adults with high normal and impaired fasting glucose (fasting plasma glucose, 100-125 mg/dl)JPRN-UMIN000032373Kao Corporation18
